Main Session
Sep
27
QP 01 - Multidimensional Toxicity in Breast Cancer Radiotherapy: Integrating Clinical, Patient-Reported, and Biological Outcomes
1000 - Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study
Presenter(s)
Jiaxuan Li, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing